JOHNSON B KRISTINE 4

What Happened
Kristine B. Johnson, a director of AtriCure, received a grant of 6,144 restricted shares on May 18, 2026. The shares were acquired at $0.00 (a compensation award), so no cash was paid; total reported acquisition value is $0. This was a grant/award (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-05-18; Filing date: 2026-05-20 (appears timely within the 2-business-day reporting window).
• Security: Common stock; Shares acquired: 6,144; Price per share: $0.00; Reported value: $0.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The shares were issued under the AtriCure, Inc. 2023 Stock Incentive Plan as a Restricted Stock Award and will vest on the one-year anniversary of the grant (May 18, 2027).
• Transaction code: A (award/grant/acquisition).

Context
Restricted stock awards are compensation and vest over time; they signal executive/director pay rather than an immediate market buy or sell. Because these shares vest in one year, Johnson will not have full ownership until vesting conditions are met.